Dermapharm Holding SE (VIE:DMP)

Market Cap	2.07B
Revenue (ttm)	1.17B
Net Income (ttm)	116.03M
Shares Out	n/a
EPS (ttm)	2.15
PE Ratio	17.86
Forward PE	16.00
Dividend	0.90 (2.43%)
Ex-Dividend Date	Jun 27, 2025

Volume	n/a
Average Volume	64
Open	37.30
Previous Close	37.45
Day's Range	37.30 - 37.70
52-Week Range	32.05 - 42.45
Beta	n/a
RSI	61.76
Earnings Date	Mar 17, 2026

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as product...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 3,610
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: DMP

Financial Performance

In 2024, Dermapharm Holding SE's revenue was 1.20 billion, an increase of 3.89% compared to the previous year's 1.15 billion. Earnings were 113.79 million, an increase of 82.44%.